Li Chen1, Guo-Sheng Ren, Fan Li, Shan-Quan Sun. 1. Department of General Surgery, the First Affiliated Hospital of Chongqing Medical Uni-versity, Chongqing 400016, China.
Abstract
AIM: To investigate the role of livin and vascular endothelial growth factor (VEGF) in human esophageal carcinoma, and analyze its relationship to clinical stages. METHODS: Expression of livin in fresh esophageal cancer tissues was detected by immunohistochemistry (IHC), Western blotting and reverse transcriptase-polymerase chain reaction (RT-PCR), and VEGF by Western blotting and RT-PCR. All statistical analyses were performed by SPSS version 11.0. RESULTS: Livin positivity was also significantly correlated with tumor stages, increasing with tumor progression. Expression of livin and VEGF increased with the process of esophageal carcinoma. In the fourth clinical stage, expression of livin and VEGF was the most significant. Expression of Livin was positively correlated with VEGF. CONCLUSION: Over-expression of livin and VEGF contributes to the pathogenesis of esophageal carcinoma.
AIM: To investigate the role of livin and vascular endothelial growth factor (VEGF) in humanesophageal carcinoma, and analyze its relationship to clinical stages. METHODS: Expression of livin in fresh esophageal cancer tissues was detected by immunohistochemistry (IHC), Western blotting and reverse transcriptase-polymerase chain reaction (RT-PCR), and VEGF by Western blotting and RT-PCR. All statistical analyses were performed by SPSS version 11.0. RESULTS:Livin positivity was also significantly correlated with tumor stages, increasing with tumor progression. Expression of livin and VEGF increased with the process of esophageal carcinoma. In the fourth clinical stage, expression of livin and VEGF was the most significant. Expression of Livin was positively correlated with VEGF. CONCLUSION: Over-expression of livin and VEGF contributes to the pathogenesis of esophageal carcinoma.
Authors: Aparna A Kamat; William M Merritt; Donna Coffey; Yvonne G Lin; Pooja R Patel; Russell Broaddus; Elizabeth Nugent; Liz Y Han; Charles N Landen; Whitney A Spannuth; Chunhua Lu; Robert L Coleman; David M Gershenson; Anil K Sood Journal: Clin Cancer Res Date: 2007-12-15 Impact factor: 12.531
Authors: T Nedelcu; B Kubista; A Koller; I Sulzbacher; I Mosberger; F Arrich; K Trieb; R Kotz; C D Toma Journal: J Cancer Res Clin Oncol Date: 2007-07-14 Impact factor: 4.553
Authors: N Wagener; I Crnković-Mertens; C Vetter; S Macher-Göppinger; J Bedke; E F Gröne; H Zentgraf; M Pritsch; K Hoppe-Seyler; S Buse; A Haferkamp; F Autschbach; M Hohenfellner; F Hoppe-Seyler Journal: Br J Cancer Date: 2007-10-30 Impact factor: 7.640
Authors: Rama Rathore; Jennifer E McCallum; Elizabeth Varghese; Ana-Maria Florea; Dietrich Büsselberg Journal: Apoptosis Date: 2017-07 Impact factor: 4.677